πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for β€œ-” Clear

  1. sodium nitrite

    NITHIODOTE

    INTRAVENOUS, INTRAVENOUS FDA: approved

  2. sodium nitroprusside

    SODIUM NITROPRUSSIDE Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  3. sodium oxybate

    XYREM Amneal Pharma Europe Ltd

    ORAL FDA: approved Β· EMA: approved

    N07XX04
  4. sodium phenylbutyrate

    PHEBURANE Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    A16AX03
  5. sodium phosphate p-32

    SODIUM PHOSPHATE P 32

    INJECTION, ORAL FDA: approved

  6. sodium phosphate, dibasic, anhydrous

    MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE

    ORAL FDA: approved

  7. sodium phosphate, dibasic, heptahydrate

    SODIUM PHOSPHATES IN PLASTIC CONTAINER Regeneron Ireland Designated Activity Company (DAC)

    INTRAVENOUS FDA: approved

  8. sodium polystyrene sulfonate

    RESONIUM-A Sanofi-aventis Healthcare Pty Ltd

    ORAL, RECTAL FDA: approved Β· TGA: approved

  9. sodium succinate

    SODIUM SUCCINATE

    INJECTION FDA: approved

  10. sodium tetradecyl sulfate

    SOTRADECOL

    INJECTION FDA: approved

  11. sodium thiosulfate

    PEDMARQSI FENNEC PHARMACEUTICALS INC.

    INJECTION FDA: approved Β· EMA: approved

  12. sodium thiosulfate (use as additive only)

    NULL

    TGA: approved

  13. sodium zirconium cyclosilicate

    LOKELMA

    ORAL FDA: approved Β· EMA: approved

    V03AE10
  14. sofosbuvir + velpatasvir

    EPCLUSA Gilead Sciences Pty Limited

    TGA: approved

  15. sofosbuvir + velpatasvir + voxilaprevir

    VOSEVI Gilead Sciences Pty Limited

    TGA: approved

  16. sofpironium bromide

    SOFDRA

    TOPICAL FDA: approved

  17. solifenacin succinate

    SOLIFENACIN SUCCINATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  18. solriamfetol hydrochloride

    SUNOSI Axsome Therapeutics

    ORAL FDA: approved

  19. somapacitan-beco

    SOGROYA

    SUBCUTANEOUS FDA: approved

  20. somatrogon-ghla

    NGENLA

    INJECTION FDA: approved

  21. somatropin [rdna origin]

    NUTROPIN

    INJECTION FDA: approved

  22. somatropin recombinant

    ZORBTIVE

    INJECTION FDA: approved

  23. sonidegib phosphate

    ODOMZO

    ORAL FDA: approved

  24. sorafenib tosylate

    NEXAVAR Teva Pharma GmbH

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources